HERMA THOMPSON: Open Payments
NPI 1871242776 · EAST ORANGE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 22 payments from 8 companies in 2025. Trend: 2023 $171 · 2024 $311 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $93 |
| Teva Pharmaceuticals USA, Inc. | 3 | $58 |
| Janssen Pharmaceuticals, Inc | 3 | $54 |
| Neurocrine BioSciences, Inc. | 3 | $51 |
| Luye Pharma (USA) Ltd. | 2 | $36 |
| Lundbeck LLC | 2 | $35 |
| Alkermes, Inc. | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
Products named: REXULTI, INVEGA SUSTENNA, INGREZZA, ABILIFY ASIMTUFII, UZEDY, ERZOFRI EXTENDED-RELEASE, ARISTADA, COBENFY.
Industry payments across NJ — which companies pay providers there.
